Because the defect in Cl-secretion exhibited by cystic fibrosis (CF) epithelia reflects regulatory rather than conductive abnormalities of an apical membrane Cl-channel, we investigated the role of different regulatory pathways in the activation of Cl-secretion in freshly excised normal and CF nasal epithelia mounted in Ussing chambers. A 8 agonist (isoproterenol IISOI), a Ca2" ionophore (A23187), and a phorbol ester (PMA) were all effective Cl-secretagogues in normal human nasal epithelia. Agonist addition studies indicated that ISO and PMA but not A23187 may share a common regulatory pathway. In contrast, only A23187 induced Cl-secretion in CF epithelia. Bradykinin raised cytosolic Ca2" and induced Clsecretion in both normal and CF tissues, indicating that receptor gated Ca2" dependent Cl-secretory mechanisms were preserved in CF. The defective Cl-secretory response in CF epithelia to ISO and PMA did not reflect abnormalities in cAMP-dependent (A) and phospholipid Ca2"-dependent (C) kinase activities. We conclude that (a) a Ca2"-sensitive mechanism for regulating Cl-secretion is maintained in CF airway epithelia, and (b) a regulatory pathway shared by two distinct protein kinases is defective in CF, indicating that the CF genetic lesion is not tightly coupled to a single (e.g., cAMP dependent) regulatory mechanism.
Introduction
The defective C1-transport exhibited by cystic fibrosis (CF)' airway epithelia reflects a defect(s) in regulatory processes rather than the conduction properties of apical membrane Clchannels (1, 2) . Most studies agree that normal but not CF cells respond to agonists or cAMP-dependent kinase with activation of Cl-secretion or channels (1) (2) (3) (4) (5) (6) . However, because of the difficulty in obtaining human tissues, a characterization of other important regulatory pathways that control human airway Cl-secretion has not been reported. Widdicombe raised the possibility that Ca2" ionophores function as Cl-secreta-gogues in cultured CF airway epithelia (7) . However, patch clamp studies yielded conflicting results with respect to whether cultured airway epithelia exhibit a Ca2l-dependent mechanism for activation of Cl-channels (1, 2) .
Therefore, the present study was undertaken with three specific aims. First, employing pharmacologic agonists of different classes, we sought to characterize the important pathways, and their interactions, that control Cl-secretion in freshly excised normal and CF airway epithelia. Secondly, we tested whether Cl-secretion can be induced in CF epithelia by both receptor-gated and ionophore-induced increases in cytosolic Ca2+. Thirdly, because of the absent Cl-secretory response to both isoproterenol and PMA in CF, we compared the form and activities of the intracellular enzymes that mediate the actions of these agonists (cAMP-dependent protein kinase [8] and protein kinase C [9] ) in CF and normal cells.
Methods

Subjects
Nasal tissues were excised from 41 normal subjects (32±4 yr old); 22 males and 19 females were included. Tissues from all subjects were obtained from the operating room, typically after general anesthesia. The nasal polyps were excised from 16 cystic fibrosis patients (aged 14±5 yr; seven females, nine males). All CF patients had typical diagnostic clinical criteria for the disease and elevated sweat electrolytes.
Chemicals and solutions
Chemicals were obtained from the following sources. Hepes, bradykinin (BK) isoproterenol, PGE,, isobutyl methyl xanthine (IBMX), and ampholines were obtained from Sigma Chemical Co., St. Louis, MO. LTC4 and 15S-hydroperoxieicosa-5Z, 8Z, 1 1Z, 13E-tetraneonic acid (15-HPETE) were obtained from Biomol, Plymouth Meeting, PA. PMA and A23187 were obtained from Calbiochem-Behring Corp., San Diego, CA or Sigma Chemical Co. The acetoxymethylester of Fura-2 (Fura-2/AM) was purchased from Molecular Probes, Eugene, OR. Bumetanide was a gift of Leo Pharmaceuticals; amiloride was a gift of Merck, Sharpe & Dohme, West Point, PA.
For bioelectric studies, a standard mammalian Krebs-Ringer bicarbonate buffer (KRB) was employed (3). For studies of intracellular Ca2l levels, the NaCl Ringer contained the following (in millimolar): 150 NaCl, 2.5 K2HPO4, 1.0 CaCI2, 1.0 MgCl2, 5.0 glucose, and 10
Hepes, adjusted to pH 7.40 (37°C) with N-methyl-D-glucamine base.
In vitro bioelectric studies
Freshly excised specimens were mounted in Ussing chambers (0.25 cm2 [3, 10] ), short-circuited, and exposed to amiloride (10-4 M, luminal bath). The effects of log increasing additions of agonists (added bilaterally every 3 min) on short circuit current (ISC) were tested. The following agonists were tested in the ranges listed: A23187, 1i-9 to 3 X 10-6 M; PGE,, 10-" to 10-6 M; isoproterenol 10-9 to 10-5 M; phorbol myristate acetate (PMA), 10-" to 10-6 M; leukotriene C4 (LTC4), 10-" to Il0`M; and 15-HPETE, 10-8 to 3 X 10-5 M. Because tachyphylaxis was observed in preliminary studies with BK, as previously observed in canine trachea (1 1), a single maximal concentration of BK (l0-5 M) was added to the mucosal surface. In some cases after amiloride addition, a blocker of Cl-secretion (bumetanide, CF nasal epithelia induced by addition of maximal effective concentrations of Cl-secretagogues of different pharmacologic classes. The mean I,, of normal and CF tissues was 63±4 and 143±13 uA * cm-', respectively before amiloride exposure and 26±3 and 5±3 ,A . cm-2 after amiloride, respectively. The half-maximal effective concentrations (EC50) of agonists in normal tissues were as follows (M): isoproterenol (ISO), 5 X 10-8; A23187, 5 X l0-7; PMA, 10-9; LTC4, 10-9; PGE1, l0-7; 15-HPETE, 10-6. The maximal effective concentrations in normals were as follows (M): ISO, 10-6; A23187, 10-6; 15-HPETE, 10-5; PGEI, l0-7; LTC4, 10-8; PMA, l0-7. The EC50 for A23187 in CF tissues was 6 X l0-7 M; the maximal effective concentration was 10-6 M. n denotes number of different patients. Mean±SEM displayed.
10-4 M [12] ) was added to the submucosal surface 30 min before subsequent addition of A23187, BK, or PMA. Finally, cumulative agonist addition experiments, employing maximal concentration(s) of agonists, were performed in CF and normal tissues.
Cell culture
Cells from freshly excised nasal specimens were grown in an F-12 hormone-supplemented medium as previously described (13) cAMP RIA Cells were cultured on collagen matrices and grown to confluency. Preliminary time course studies indicated that cAMP levels peaked after a 10-min incubation with the agonists tested. A basal sample (time 0) was obtained after which a 0-min incubation in F12 medium containing the following agent(s) was carried out: isoproterenol (l0 cAMP-dependent kinase assay. cAMP-dependent protein kinase activities contained in the cytosolic fractions of normal and cystic fibrosis cells were assayed by the technique ofGill and Walton (17). In brief, aliquots of cytosol normalized for protein ( Characterization ofprotein kinase C (PKC)
Measurement of whole-cell PKC activity. PKC activity of extracted whole-cell homogenates of cystic fibrosis and normal cultured cells were compared by the technique of Halsey et al. (19) . Cells were homogenized in the buffer described above, the membrane-associated PKC was extracted by incubation for 30 min at 0°C with 0.3% Triton X-100, and a 100,000-g supernatant was prepared. experiment. PMA (l0-7 M) was added to the cultures for 10 min, cultures were rinsed with phosphobuffered saline (pH 7.4) and the incubation was stopped by adding electrophoresis buffer containing 9.5 M urea, 2% NP40, 2% ampholines (pH 3-10), and 5% fl-mercaptoethanol. 25-Ml aliquots of sample were subjected to nonequilibrium pH gradient electrophoresis followed by 10% PAGE in the second dimension (20) . Gels were dried and subjected to autoradiography on AR film (Eastman Kodak Co., Rochester, NY).
Distribution ofPKC activity. Cytosol and membrane fractions were prepared as above. The particulate fractions were solubilized with 0.3% Triton X-100 and recentrifuged at 100,000 g for 30 min. The activities of cytosol and solubilized particulates were measured using the standard PKC assay. In addition, to compare endogenous substrates in CF and normal cells, cytosol and solubilized membrane fractions were prepared as described above and incubated with [y-32P]ATP and with or without the addition of PS, D, and Ca2". Aliquots were electrophoresed on one-dimensional 10% SDS-PAGE gels, stained with Coomassie blue, destained, dried, and subjected to autoradiography.
Results
The nasal epithelial C1-secretory response to potential C1-secretagogues (1, 2, 21-25) was measured as the change in ISC in tissues pretreated with amiloride to abolish the component ofactive Na+ absorption to the ISC (3, 7). In normal tissues (Fig.  1 A) , isoproterenol and A23187 were equieffective. PMA, an activator of PKC (9) , routinely induced Cl-secretion but was less effective, as reported in canine trachea (24, 25 In contrast to normal tissues, only A23187 raised I,, in amiloride pretreated CF tissues (Fig. 1 B) . The A23187-induced response in CF differed from normals in that the maximal increase was smaller (-60% of the AIs, in normals) and the effect was shorter in duration. Cl-secretion could be induced in CF tissues bathed on the mucosal surface with a
Ringer solution with 500 nM Ca2l and exposed to mucosal A23187. This observation indicates that unphysiological levels of cytosolic Ca2' may not be required to induce Cl-secretion (also see Table I ). The increase in Ih, induced by A23187 in CF tissues was partially inhibited by bumetanide pretreatment (62% inhibition; AIsh = 4.6±0.1 uA cm-2, n = 4), indicating that at least a major fraction of the stimulated I,, reflects the induction of chloride secretion. Studies of drug interactions with the Cl-secretory path were performed in normal nasal epithelia with cumulative additions of maximal effective agonist concentrations (Fig. 2 A) . Isoproterenol, added during the maximal sustained (5 min) effect of A23187, routinely further increased the Cl-current; A23187 also routinely added to the maximal sustained effect induced by isoproterenol. Similarly, A23187 added to the C1-current induced by maximal effective concentrations of PMA, and PMA added to the maximal response induced by A23187. In contrast, isoproterenol added to the maximal effect induced by PMA but PMA did not add to the maximal I,, induced by isoproterenol. Consequently, whereas fully additive effects were not observed between A23187 and isoproterenol or PMA, the highly reproducible increment in Is, after A23187 addition to isoproterenol or PMA prestimulated tissues indicates that components of the Ca2+-dependent pathway(s) are separate from the isoproterenol-and/or PMA-dependent path. In CF, no combination of PMA or isoproterenol with A23187 induced a larger response than A23187 alone (Fig. 2  B) . The combination of PMA and isoproterenol was ineffective.
The interactions between these agonists were explored at the level of cAMP accumulation. As shown in Fig. 3 , isoproterenol and forskolin were potent stimulators of cAMP accu- Ca2+ levels between CF and normals were noted, as previously reported (26) . BK-induced rapid rises (Fig. 4) in intracellular Ca2" levels that were not different in CF and normal (Table I ).
The response ofthe IC to BK administration is shown in Fig. 5 and summarized in Table I . In amiloride-pretreated tissues, BK induces a rapid increase in ISc with a variable plateau phase. Pretreatment with bumetanide inhibited the maximal BK-induced change in IC by 65% to 74% in normal and CF tissues, respectively.
The defect in CF Cl-secretion in response to isoproterenol and PMA was further explored by measuring the maximal stimulated activities of protein kinase activities of cells cultured from CF and normal subjects. Fig. 6 normal, the type II (RI, containing) isoform of the cAMP-dependent kinase was the dominant isoform in both CF and normal cells (Fig. 7) . We next tested whether total PKC activity differed in CF and normal cells. Total cell PKC activity, measured at maximally stimulating concentrations of PS and D (18) after quantitative extraction of homogenates with 0.3% Triton X-100, was not different in CF and normal cells (Fig. 8) . Further, fractionation of PKC activity into cytosolic and detergent extractable particulate fractions showed that > 80% of the basal activity resided in the cytosolic compartment in both CF and normal cells.
Endogenous substrates in the cytosol and extracted membrane fractions were studied in the absence and,presence ofPS, In normal human airway epithelia, agonists that raise cytosolic
Cal' or that activate cAMP-dependent protein kinase (isoproterenol) or PKC (PMA) induce Cl-secretion. In contrast, only a Ca2'-dependent C1-secretory mechanism appears functional in freshly excised CF nasal epithelia (7, 27 increases in cytosolic Ca2" (Fig. 4) . These findings indicate that (a) the coupling mechanisms, presumably inositol trisphosphate mediated, for receptor activation and increases in cytosolic Ca2" activities are intact in CF cells and (b) that receptorgated increases in Ca2" levels are equieffective in initiating Clsecretion in CF and normal cells. This finding consequently provides an important physiologic control for the specificity of action of calcium ionophore responses. Like the actions of A23187, the mechanism ofactivation ofCl-secretion by BK is not clear. However, the failure ofexogenous additions of PMA or eicosanoids to initiate Cl-secretion in CF tissues makes it likely that BK-induced increases in cell Ca2" levels are working through a mechanism that does not involve activation of PKC or phospholipase A2, respectively.
As previously shown in fresh tissue (4, 30) and cultured cells (2, 26) , the failure of CF tissues to respond to C1-secretagogues of the beta adrenergic class is not due to a failure to produce cAMP. The data in Fig. 6 confirm the report of Berthelson and Widdicombe (31) that cytosolic A kinase in CF and normal cells exhibits the same maximal activity in the presence of exogenous cAMP. In addition, the data in Fig. 7 indicate that the RI, isoform ofthe A kinase dominates in both CF and normal airway epithelia. The observation that the RI, isoform is expressed in airway epithelia suggest that this form, which is often associated with the plasma membrane, is present in respiratory epithelial cells. Preliminary patch clamp data indicate that cAMP plus ATP can activate Cl-channels in off cell patches of airway epithelium, consistent with the notion that some kinase is membrane associated (32) .
A second key finding in this study is that the PKC system appears to have a role in the activation of Cl-secretion in normal human tissues but is ineffective in inducing Cl-secretion in CF tissues. Whereas PKC isoforms were not compared in CF and normal airway epithelia, several types of experiments indicate that total PKC activity is similar in CF and normals. Assays of total cell PKC activity do not detect a difference in maximal activity between CF and normal tissues (Fig. 8) . Our experiments also indicate that the distribution of basal PKC activity in cytosol (> 80% of activity) and membrane fractions are equivalent, as is the ability to phosphorylate endogenous substrates in cell-free assays (Fig. 9) . Lastly, the capacity of PMA to activate PKC in intact cells also is similar in CF and normal cells (Fig. 10) . Thus, it appears that whereas normal tissues develop Cl-secretion in response to the activation oftwo independent kinases (A kinase, C kinase), CF tissues, despite apparently normal kinase activities, do not.
The finding that activation of C kinase is ineffective in initiating Cl-secretion in CF epithelia indicates that the activation defect in CF is not limited to the A kinase path. This finding increases the complexity of the CF regulatory defect, but suggests that proteins whose state of phosphorylation is governed by both A and C kinase can be considered important targets when searching for differences in CF and normal phosphoprotein profiles.
Our data suggest a complex mechanism of regulation for Cl-secretion in human airway epithelia with at least two distinct pathways. First, agents that activate A and C protein kinases appear to work via a common path that converges upon a regulatory protein(s) whose activity is altered by phosphorylation. The lack of efficacy of both isoproterenol and PMA in CF, and the failure of the two agents to act additively in normals, lend support to this concept. Secondly, evidence for a distinct calcium-dependent path is derived from the additivity of A23 187 and isoproterenol or PMA in normals, and the retention of A23 187 efficacy in CF tissues.
The retention of the Ca2l but not cAMP-dependent path for secretion in airways appears to mimic the pattern observed in the CF sweat gland wherein the cholinergic (Ca2"-mediated) but not f3-adrenergic (cAMP-mediated) path is effective in initiating sweat formation, presumably through a Cl-secretory mechanism (30) . The recent report that Ca2" ionophores and carbachol are ineffective in the CF small intestine (33) indicates retention of Ca2+-dependent mechanisms for Cl-secretion may not be a uniform feature of CF epithelium. However, the finding that increases in cell Ca2+ levels are effective initiating Cl-secretion in CF airway epithelia does raise the possibility that this mechanism may be therapeutically exploited in the future. Specifically, agents that raise cell Ca2W levels, via direct or receptor-mediated actions, may effectively initiate Cl-and water fluxes toward the airway lumen.
